PLOS -- the Public Library of Science –is a leading nonprofit publisher that seeks to make science and data publicly accessible. The organization recently published the first Open Science Indicators dataset (available for download from its website).
Professor Michael Georgieff, MD, has been inducted into the Academy for Excellence in Health Research, the highest recognition of excellence in health science research offered by the University of Minnesota. Dr.
The University’s Research Ethics Day webinar on “What Makes Your Research Trustworthy? Threats and Opportunities” will be held on Wed., March 1 at 9:00am - 3:00pm Central Time by Zoom.
The U.S. Supreme Court made rulings in its 2021-22 term that impact public health law and will change how individuals and communities are able to manage public health challenges in the future. James G. Hodge, Jr., JD, LLM and co-authors have summarized these decisions in an article published in The Journal of Law, Medicine, and Ethics.
While Black, Hispanic, and Asian adults under the age of 65 are vaccinated at higher rates than White adults of the same age in Minnesota, COVID mortality rates for Black, Hispanic and Asian adults were higher than the mortality rate for White adults during the Delta and Omicron COVID waves, according to a recent study published in the American Journal of Preventive Medicine.
The Center for Bioethics will present “Beyond Abortion: The Consequences of Overturning Roe,” on Friday, November 18 from 12:15 - 1:30pm. The webinar will feature Mary Faith Marshall, PhD, FCCM, HEC-C, Director, Center for Health Humanities and Ethics, and Director, Program in Biomedical Ethics at the University of Virginia School of Medicine, and Lynn M. Paltrow, JD, founder, National Advocates for Pregnant Women.
Scholars from the Center for Science, Technology and Environmental Policy (CSTEP) and the University of Texas at Austin’s LBJ School of Public Affairs recently published a paper in Energy Research & Social Science that considers why some Community Based Organizations' (CBOs) participate in the clean energy transition and analyzes how
COVID-19 and its impacts have dominated the public health landscape since its emergence in late 2019. The novel pathogen that causes COVID-19 (SARS-CoV-2) is not the only coronavirus to impact humans in recent years, and likely won’t be the last. In a commentary published in the journal Vaccine, experts from the Center for Infectious Disease Research and Policy (CIDRAP) and the Mayo Clinic discuss current coronavirus vaccine limitations, as well as the challenges of developing improved coronavirus vaccines.
Researchers at the University of Minnesota’s BioTechnology Institute are using synthetic biology to create new forms of DNA that will eventually produce products useful to humans, such as drugs for treating disorders like stroke or Parkinson’s disease. They also aim to discover new ways to modify features of complex organisms to control the spread of disease or the destruction of fragile ecosystems. Prof.
Currently, there is a shortage of viable human livers for transplantation, and thousands of potentially available organs go unused each year, as livers can only be preserved for only a short time. The NSF-funded Engineering Research Center for Advanced Technologies for the Preservation of Biological Systems (ATP-BioSM) is developing new cryopreservation technologies to extend preservation times for biological material.